The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Sep. 23, 2025
Filed:
Apr. 05, 2023
Applicant:
Tvax Biomedical I, Llc, Olathe, KS (US);
Inventors:
Gary Wood, Olathe, KS (US);
Jochen Harald Stritzker, La Jolla, CA (US);
Assignee:
TVAX Biomedical I, LLC, Olathe, KS (US);
Primary Examiner:
Int. Cl.
CPC ...
A61K 35/68 (2006.01); A61K 35/17 (2015.01); A61K 35/76 (2015.01); A61K 35/768 (2015.01); A61K 39/00 (2006.01); A61P 35/00 (2006.01);
U.S. Cl.
CPC ...
A61K 35/768 (2013.01); A61K 35/17 (2013.01); A61K 35/76 (2013.01); A61K 39/0011 (2013.01); A61P 35/00 (2018.01); A61K 2039/5158 (2013.01); A61K 2039/545 (2013.01); Y02A 50/30 (2018.01);
Abstract
The present invention relates to augmenting the effects of adoptive T cell therapy, such as TVAX Immunotherapy, using adjunct treatment with an oncolytic virus, such as a vaccinia virus, to treat various types of cancer or other proliferative disorders. Immunomodulatory compounds can be used to further augment to effects of the therapy.
Wood, Gary. (2025). Methods for combining adoptive t cell therapy with oncolytic virus adjunct therapy (U.S. Patent No. 12419924). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/12419924
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile